Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modulated Electro-hyperthermia in Cervical Cancer
NCT03332069Phase 3Unknown
- Start
- Jan 2014
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms). Primary endpoint: Local Disease Control at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT03332069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03332069.